XML 228 R73.htm IDEA: XBRL DOCUMENT v3.25.0.1

Summary of Significant Accounting Policies - Schedule of Consolidated Financial Statements (Details)			12 Months Ended
		Mar. 31, 2024	Jun. 30, 2024
Moolec Science Limited [Member]
Schedule of Consolidated Financial Statements [Line Items]
Principal activities	[1]		Investment in subsidiaries
Country of incorporation and principal place of business	[1]		United Kingdom
% Equity interest as of March 31, 2024	[1]	100.00%
LightJump Acquisition Corporation [Member]
Schedule of Consolidated Financial Statements [Line Items]
Principal activities			Investment in subsidiaries
Country of incorporation and principal place of business			USA
% Equity interest as of March 31, 2024		100.00%
ValoraSoy S.A. [Member]
Schedule of Consolidated Financial Statements [Line Items]
Principal activities			Investment in subsidiaries
Country of incorporation and principal place of business			Argentina
% Equity interest as of March 31, 2024		100.00%
AG Biomolecules LLC (DE) [Member]
Schedule of Consolidated Financial Statements [Line Items]
Principal activities			Investment in subsidiaries
Country of incorporation and principal place of business			USA
% Equity interest as of March 31, 2024		100.00%
Microo Foods Ingredients S.L. [Member]
Schedule of Consolidated Financial Statements [Line Items]
Principal activities			Investment in joint arrangements
Country of incorporation and principal place of business			Spain
% Equity interest as of March 31, 2024		50.00%
[1] Moolec Science Limited has a branch office in Argentina, Moolec Science Limited S.E.

X

- Definition

The country in which the entity is incorporated.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2024-01-01
-Paragraph 138
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_138_a&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_CountryOfIncorporation
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The country in which a subsidiary of the entity is incorporated. [Refer: Total for all subsidiaries [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2024-01-01
-Paragraph 16
-Subparagraph b
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b_ii&doctype=Standard
-URIDate 2024-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2024-01-01
-Paragraph 17
-Subparagraph b
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b_ii&doctype=Standard
-URIDate 2024-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2024-01-01
-Paragraph 12
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_12_b&doctype=Standard
-URIDate 2024-03-27

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2024-01-01
-Paragraph 19B
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_19B_b&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The proportion of the voting rights in a subsidiary held by the entity. [Refer: Total for all subsidiaries [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2024-01-01
-Paragraph 17
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b_iii&doctype=Standard
-URIDate 2024-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2024-01-01
-Paragraph 16
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b_iii&doctype=Standard
-URIDate 2024-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2024-01-01
-Paragraph 19B
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_19B_c&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_ProportionOfVotingPowerHeldInSubsidiary
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:percentItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecScienceLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_LightJumpAcquisitionCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_ValoraSoySAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_AGBiomoleculesLLCDEMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MicrooFoodsIngredientsSLMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: